Compare SKYX & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SKYX | ORGO |
|---|---|---|
| Founded | 2004 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.8M | 166.0M |
| IPO Year | 2014 | 2016 |
| Metric | SKYX | ORGO |
|---|---|---|
| Price | $0.88 | $1.04 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 2 |
| Target Price | ★ $4.00 | $2.00 |
| AVG Volume (30 Days) | 632.7K | ★ 750.4K |
| Earning Date | 11-11-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 11.11 | ★ 1600.00 |
| EPS | ★ N/A | N/A |
| Revenue | $7,700,948.00 | ★ $564,169,000.00 |
| Revenue This Year | $16.10 | N/A |
| Revenue Next Year | $27.95 | $37.55 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 9.78 | ★ 17.04 |
| 52 Week Low | $0.88 | $0.93 |
| 52 Week High | $3.29 | $7.08 |
| Indicator | SKYX | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 24.55 | 26.19 |
| Support Level | N/A | N/A |
| Resistance Level | $1.29 | $2.57 |
| Average True Range (ATR) | 0.06 | 0.08 |
| MACD | -0.02 | -0.01 |
| Stochastic Oscillator | 11.31 | 22.22 |
SKYX Platforms Corp operates in the business of developing proprietary technology that enables a quick and safe installation of electrical fixtures, such as light fixtures and ceiling fans. Its technology consists of a weight-bearing, fixable socket and a revolving plug for conducting electric power and supporting an electrical appliance attached to a wall or ceiling. The socket is comprised of a nonconductive body that houses conductive rings connectable to an electric power supply through terminals in its side exterior. The plug is also comprised of a nonconductive body that houses corresponding conductive rings, attaches to the socket via a male post, and is capable of feeding electric power to an appliance. It generates its income from lighting and heating products sold in the USA.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.